ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 53

$904K Total Retail Price of All Prescriptions

Rank: 12 out of 53

468 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 468 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

14% of this provider’s 468 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 9,574 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $123 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
FUROSEMIDE 430 389 1 16
LISINOPRIL 426 337 2 8
LEVOTHYROXINE SODIUM 402 329 3 1
HYDROCODONE-ACETAMINOPHEN 380 293 S3 4 15
CITALOPRAM HBR 274 247 5 58
POTASSIUM CHLORIDE 254 210 6 30
LANTUS 242 151 7 7
GABAPENTIN 222 151 8 21
OMEPRAZOLE 215 151 9 24
AMLODIPINE BESYLATE 210 204 10 18
SIMVASTATIN 209 161 11 6
METFORMIN HCL 198 166 12 3
PRAVASTATIN SODIUM 196 157 13 17
METOPROLOL TARTRATE 179 146 14 26
NOVOLOG 164 109 15 19
LANTUS SOLOSTAR 161 103 16 5
QUETIAPINE FUMARATE 159 134 17 108
RANITIDINE HCL 158 139 18 81
VENLAFAXINE HCL ER 150 98 19 113
ALLOPURINOL 129 117 20 51
TRAZODONE HCL 117 95 21 91
WARFARIN SODIUM 110 110 22 64
POLYETHYLENE GLYCOL 3350 109 100 23 89
BUSPIRONE HCL 108 105 24 94
CYCLOBENZAPRINE HCL 107 51 R 25 97
LOSARTAN POTASSIUM 105 82 26 27
GLIMEPIRIDE 99 69 27 10
INSULIN SYRINGE 98 46 28 9
SPIRONOLACTONE 94 66 29 59
DIGOXIN 94 83 29 114
TRAMADOL HCL 93 73 31 71
METOPROLOL SUCCINATE 91 87 32 34
DONEPEZIL HCL 90 84 33 92
NAMENDA 88 82 34 94
CLONIDINE HCL 87 81 35 69
CIPROFLOXACIN HCL 83 74 36 140
SERTRALINE HCL 83 67 36 63
SODIUM CHLORIDE 80 40 38 141
GLYBURIDE 79 64 R 39 57
HYDROCHLOROTHIAZIDE 76 63 40 28
PEN NEEDLE 76 62 40 4
METOLAZONE 76 75 40 144
LYRICA 72 50 43 88
HUMALOG 71 54 44 11
SEROQUEL 70 63 45 155
NOVOLOG FLEXPEN 68 40 46 13
IBUPROFEN 68 23 46 107
PAROXETINE HCL 67 55 48 119
CARVEDILOL 64 63 49 61
NORTRIPTYLINE HCL 63 61 50 164
PLAVIX 62 60 51 65
DIOVAN 62 48 51 75
NEXIUM 61 43 53 35
ALENDRONATE SODIUM 61 53 53 44
PRAMIPEXOLE DIHYDROCHLORIDE 59 47 55 168
BACLOFEN 58 27 56 170
JANUVIA 58 41 56 14
AMOXICILLIN 58 46 56 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 47 59 78
CARBIDOPA-LEVODOPA 53 53 60 176
NEOMYCIN-POLYMYXIN B 53 35 10 60 176
SYNTHROID 52 40 62 2
RISPERIDONE 51 38 63 133
PANTOPRAZOLE SODIUM 51 49 63 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.